Targeting the lysine methyltransferase Suv39h1 in cardiac fibroblasts attenuates post-infarct myocardial fibrosis
Life Sciences · 2026
DOI: 10.1016/j.lfs.2026.124221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026. Verfasst von Shuai Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Cardiovascular Diseases Research of Hainan Province, Medical Research Center of the First Affiliated Hospital, Hainan Wome…. Hauptthemen laut MEDLINE: Myocardial Infarction, Methyltransferases, Fibroblasts, Repressor Proteins. Die Arbeit nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hainan Province.
Abstract (Originalsprache)
AIMS: Adverse ventricular remodeling following myocardial infarction contributes to heart failure. Following cardiac injury, quiescent fibroblasts trans-differentiate into myofibroblasts and produce extracellular matrix proteins to initiate ventricular remodeling. We investigated the role of Suv39h1, a lysine methyltransferase, in this process. METHODS: Myocardial infarction was induced by permanent ligation of the left anterior descending (LAD) coronary artery. RESULTS: Suv39h1 expression was up-regulated in cardiac fibroblasts isolated from mice subjected to the LAD procedure compared to the sham procedure mirroring the induction of Periostin, a myofibroblast marker. Reporter assay and chromatin immunoprecipitation (ChIP) assay showed that C/EBPβ was recruited to the Suv39h1 promoter to mediate Suv39h1 trans-activation by pro-fibrogenic stimuli in fibroblasts. Genetic deletion of Suv39h1 from either quiescent fibroblasts or activated fibroblasts (myofibroblasts) in mice attenuated cardiac fibrosis and rescued the decline of heart function following myocardial infarction. Importantly, administration of a small-molecule Suv39h1 inhibitor F5446 ameliorated cardiac fibrosis and partially normalized heart function in mice following myocardial infarction. RNA-seq identified several potential Suv39h1 targets that might contribute to fibroblast-myofibroblast transition. SIGNIFICANCE: In conclusion, our data demonstrate that Suv39h1 might play an important role regulating ventricular remodeling in ischemic cardiomyopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Tropical Cardiovascular Diseases Research of Hainan Province, Medical Research Center of the First Affiliated Hospital, Hainan Women and Children Medical Center, Key Laboratory of Emergency and Trauma…
- Center for Experimental Medicine, Jiangsu Health Vocational College, Nanjing, China; State Key Laboratory of Natural Medicines, Department of Pharmacology, China Pharmaceutical University, Nanjing, China.
- Center for Experimental Medicine, Jiangsu Health Vocational College, Nanjing, China.
- Center for Experimental Medicine, Jiangsu Health Vocational College, Nanjing, China. Electronic address: mmfang@jshvc.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hainan Province
Zitieren
APA
Liu, S., Wu, X., Xue, Y., Qi, M., Li, T., Zhang, Y., & Fang, M. (2026). Targeting the lysine methyltransferase Suv39h1 in cardiac fibroblasts attenuates post-infarct myocardial fibrosis. Life Sciences. https://doi.org/10.1016/j.lfs.2026.124221
Vancouver
Liu S, Wu X, Xue Y, Qi M, Li T, Zhang Y, et al. Targeting the lysine methyltransferase Suv39h1 in cardiac fibroblasts attenuates post-infarct myocardial fibrosis. Life Sciences. 2026. doi:10.1016/j.lfs.2026.124221
BibTeX
@article{Liu2026,
author = {Liu, Shuai and Wu, Xiaoping and Xue, Yujia and Qi, Mengwen and Li, Tianfa and Zhang, Yuanyuan and Fang, Mingming},
title = {Targeting the lysine methyltransferase Suv39h1 in cardiac fibroblasts attenuates post-infarct myocardial fibrosis},
journal = {Life Sciences},
year = {2026},
doi = {10.1016/j.lfs.2026.124221}
}
EUVIMED